Discounted Cash Flow
GE Healthcare Technologies Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2021 | $17.6b | $2.2b | $-214.0m | 12.8% | $5.01 |
| 2022 | $18.3b (4.3%) | $1.9b (-14.7%) | $-125.0m (41.6%) | 10.4% (-18.2%) | $4.29 (-14.3%) |
| 2023 | $19.6b (6.6%) | $1.6b (-18.2%) | $79.0m (163.2%) | 8.0% (-23.2%) | $3.56 (-17.2%) |
| 2024 | $19.7b (0.6%) | $2.0b (27.1%) | $-342.0m (-532.9%) | 10.1% (26.3%) | $4.50 (26.4%) |
| 2025 | $20.6b (4.8%) | $2.1b (4.6%) | $-491.0m (-43.6%) | 10.1% (-0.3%) | $4.72 (5.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.